Ad is loading...
RPMGX vs TCGRX
RPMGX vs TCGRX Comparison
Open Charts RPMGX vs TCGRX
T. Rowe Price Mid-Cap Growth
Price$104.46
Change+$1.15 (+1.11%)
VolumeN/A
Net Assets30.9B
Thornburg Small/Mid Cap Growth R4
Price$32.56
Change+$0.52 (+1.62%)
VolumeN/A
Net Assets277.95M
RPMGX vs TCGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
RPMGX vs. TCGRX commentary
Jan 31, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a StrongBuy and TCGRX is a Hold.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 30.9B vs. TCGRX (278M). RPMGX pays higher dividends than TCGRX: RPMGX (0.05) vs TCGRX (0.00). RPMGX was incepted earlier than TCGRX: RPMGX (33 years) vs TCGRX (18 years). TCGRX is a more actively managed with annual turnover of: 57.56 vs. RPMGX (21.70). TCGRX has a lower initial minimum investment than RPMGX: TCGRX (0) vs RPMGX (2500). TCGRX annual gain was more profitable for investors over the last year : 24.27 vs. RPMGX (4.45). RPMGX return over 5 years is better than : 10.07 vs. TCGRX (-19.43).
| RPMGX | TCGRX | RPMGX / TCGRX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 33 years | 18 years | - |
| Gain YTD | 4.743 | 4.259 | 111% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 30.9B | 278M | 11,115% |
| Annual Yield % from dividends | 0.05 | 0.00 | - |
| Returns for 1 year | 4.45 | 24.27 | 18% |
| Returns for 3 years | -0.17 | 15.63 | -1% |
| Returns for 5 years | 10.07 | -19.43 | -52% |
| Returns for 10 years | 40.15 | 19.93 | 202% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLHIX | 30.38 | 0.37 | +1.23% |
| Virtus KAR Health Sciences Inst | |||
| WVMRX | 11.78 | 0.12 | +1.03% |
| William Blair Mid Cap Value R6 | |||
| JSEPX | 42.54 | 0.39 | +0.93% |
| JPMorgan Small Cap Equity R3 | |||
| NINCX | 20.14 | N/A | N/A |
| Neuberger Berman Intrinsic Value C | |||
| JMNCX | 12.80 | -0.01 | -0.08% |
| JPMorgan Research Market Neutral C | |||